Morphotek, Inc.
Records under this name other than the patents Morphotek, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,422,367 | Antigenic GM-CSF Peptides and Antibodies to GM-CSF Formerly held In force · High confidence | In force | High confidence | |
| US 8,206,710 | Anti-mesothelin antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,389,691 | Antibodies with immune effector activity and that internalize in endosialin-positive cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,168 | Antigenic Gm-Csf Peptides and Antibodies to Gm-Csf Formerly held In force · High confidence | In force | High confidence | |
| US 8,889,846 | High affinity antibodies that neutralize Staphylococcus enterotoxin B Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,895,704 | High affinity antibodies that neutralize Staphylococcus enterotoxin B Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,359,428 | High affinity antibodies that neutralize Staphylococcus enterotoxin B Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,868,780 | High affinity antibodies that neutralize Staphylococcus enterotoxin B Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,364,284 | High affinity antibodies that neutralize Staphylococcus enterotoxin B Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,741,450 | Antigenic Gm-Csf Peptides and Antibodies to Gm-Csf Formerly held In force · High confidence | In force | High confidence |